UK markets open in 6 hours 33 minutes

MDxHealth SA (MDXH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.95-0.42 (-4.47%)
At close: 02:34PM EST
Full screen
Trade prices are not sourced from all markets
Previous close9.37
Open9.15
Bid8.95 x 800
Ask9.30 x 800
Day's range8.91 - 9.15
52-week range8.30 - 13.17
Volume2,311
Avg. volume44,403
Market cap142.818M
Beta (5Y monthly)1.38
PE ratio (TTM)N/A
EPS (TTM)-2.81
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.00
  • Globe Newswire

    MDxHealth Shareholder Transparency Declaration

    NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET MDxHealth Shareholder Transparency Declaration IRVINE, CA, and HERSTAL, BELGIUM – 10 December 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated market and

  • Globe Newswire

    MDxHealth Shareholder Transparency Declarations

    NEWS RELEASE – REGULATED INFORMATION 22 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 22 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated marke

  • Globe Newswire

    MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

    NEWS RELEASE – REGULATED INFORMATION 15 November 2021, 11:00 p.m. CET MDxHealth Shareholder Transparency Declarations IRVINE, CA, and HERSTAL, BELGIUM – 15 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage precision diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated marke